Rubella Antibodies, IgG and IgM
| Order Code: | RUBE |
| Epic Lab Code: | LAB4003 |
| Order Form: | A-1a Miscellaneous Request or Epic Req |
Commercial Mail-out Laboratory
6240 RCP
356-3527
6240 RCP
356-3527
Specimen:
Serum
Collection Medium:
![]() |
| Red top tube |
Minimum:
Adult Preferred Mimimum: 2.0 mL serum
Absolute Minimum: 0.5 mL serum
Rejection Criteria:
Contaminated, heat-inactivated or hemolyzed specimens
Analytic Time:
24 hours upon receipt at reference laboratory
Reference Range:
Rubella Antibody, IgG
Less than 5 IU/mL: Negative
No significant level of detectable rubella IgG antibody.
5-9 IU/mL: Equivocal
Repeat testing in 10-14 days may be helpful.
Greater than 10 IU/mL: Positive
IgG antibody to rubella detected, which may indicate a current
or previous exposure/immunization to rubella.
Rubella Antibody, IgM
0.89 IV of less: Negative
No significant level of detectable rubella IgM antibody.
0.90-1.09 IV: Equivocal
Repeat testing in 10-14 days may be helpful.
1.10 IV or greater: Positive
IgM antibody to rubella detected, which may indicate a current
or recent infection or immunization.
Comments:
Acute and convalescent samples must be labeled as such; parallel
testing is preferred and convalescent samples must be received within
30 days from receipt of the acute samples. Please mark sample plainly
as "acute" or "convalescent".
Test
Limitations:
In children and adults, rubella infection usually results in a mild
exanthematous disease. However, infection during pregnancy,
particularly in the first trimester, can result in fetal death or the
"rubella syndrome," a spectrum of congenital defects that includes
cataracts, deafness, glaucoma, congenital heart disease, and mental
retardation. About ten to 20 percent of newborns infected in utero fail
to survive past the first year of life. Since complications of
congenital rubella infection are so severe, diagnosis of infection
during the first trimester of pregnancy may influence the decision to
terminate or continue the pregnancy. Thus, it is important to determine
the rubella immune status in women of child-bearing age, in pregnant
women, and in individuals who may have close contact with them, such as
hospital personnel and preschool children.
In a patient suffering from a primary rubella infection, the appearance
of both IgG and IgM antibodies is associated with the appearance of
clinical signs and symptoms when present. IgM antibodies become
detectable in a few days after the onset of signs and symptoms and
reach peak levels in seven to ten days. These antibodies persist, but
rapidly diminish in concentration over the next four to five weeks
until the antibody is no longer clinically detectable. The presence of
IgM antibody in a single specimen suggests that the patient has
recently experienced a rubella infection. In most cases, the infection
probably occurred within the preceding one to three months. Rubella IgM
antibody in a newborn's serum suggests congenital infection since IgM
from the mother is not transferred to the infant across the placenta.
The infected infant, in contrast to a woman with prenatal rubella, may
continue to produce rubella-specific IgM for several months.
Methodology:
Chemiluminescent Immunoassay
CPT Code:
86317 Rubella IgG, 86762 Rubella IgM
